Acor stock price target

Acorda Therapeutics (ACOR) Stock in the Investors Queue ...

J.P. Morgan Cuts Price Target on Acorda (ACOR) Stock ... Sep 10, 2018 · Did an iceberg just wallop into Acorda (ACOR) stock? The drug maker's shares are plunging at breakneck speed of almost 22% after the U.S. Court of Appeals ACOR Acorda Therapeutics, Inc. Stock Quote Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Selincro, an orally administered drug for the treatment of alcohol dependence in Acorda Therapeutics (NASDAQ:ACOR) Stock Rating Lowered by ... ValuEngine lowered shares of Acorda Therapeutics (NASDAQ:ACOR) from a buy rating to a hold rating in a research note released on Friday morning, ValuEngine reports.. ACOR has been the subject of a number of other reports. Cowen reiterated a buy rating and issued a $10.00 price target on shares of Acorda Therapeutics in a research report on Thursday, January 16th.

Jan 24, 2020 · The most recent rating by UBS, on December 04, is at Buy, with a price target of $31.00. • Esperion Therapeutics, Inc. (NASDAQ: ESPR ) stock decreased by 9.0% to $49.46.

ACOR - Acorda Therapeutics Inc Stock quote - CNNMoney.com Find real-time ACOR - Acorda Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. ACOR - Acorda Therapeutics Inc Stock quote - CNNMoney.com Markets Analysts suggest Acorda Therapeutics Inc. (ACOR) could ... Mar 23, 2020 · The ACOR stock was last observed hovering at around $0.85 in the last trading session, with the day’s gains setting it 0.12% off its average median price target of $2.25 for the next 12 months. It is also 90.3% off the consensus price target high of $10.00 offered by 7 analysts, but current levels are 3.0% higher than the price target low of Questions Remain, But Analysts Stay Bullish: Acorda ... Mar 09, 2020 · At the time the stock opened at the value of $1.12, making it a high for the given period, the value of the stock jumped by 0.86%. After the increase, ACOR touched a low price of $1.12, calling it a day with a closing price of $1.16, which means that the price of ACOR went 1.17 below the opening price on the mentioned day. ACOR Stock Price & Charts | Acorda Therapeutics

Nov 08, 2019 · Acorda Therapeutics Inc. analyst estimates by MarketWatch. View ACOR revenue estimates and earnings estimates, as well as analyst recommendations.

Mar 06, 2020 · Investment analysts at H.C. Wainwright published a research note on August 14, 2019 where it informed investors and clients that Acorda Therapeutics Inc. (NASDAQ:ACOR) is now rated as Neutral. Their price target on the stock stands at $6. Even though the stock has been trading at $1.26/share, analysts expect it to down by -7.94% to reach $3.75

Stock quote for Acorda Therapeutics, Inc. Common Stock Common Stock (ACOR) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.

Find real-time ACOR - Acorda Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. ACOR - Acorda Therapeutics Inc Stock quote - CNNMoney.com Markets Analysts suggest Acorda Therapeutics Inc. (ACOR) could ... Mar 23, 2020 · The ACOR stock was last observed hovering at around $0.85 in the last trading session, with the day’s gains setting it 0.12% off its average median price target of $2.25 for the next 12 months. It is also 90.3% off the consensus price target high of $10.00 offered by 7 analysts, but current levels are 3.0% higher than the price target low of Questions Remain, But Analysts Stay Bullish: Acorda ... Mar 09, 2020 · At the time the stock opened at the value of $1.12, making it a high for the given period, the value of the stock jumped by 0.86%. After the increase, ACOR touched a low price of $1.12, calling it a day with a closing price of $1.16, which means that the price of ACOR went 1.17 below the opening price on the mentioned day. ACOR Stock Price & Charts | Acorda Therapeutics In depth view into ACOR (Acorda Therapeutics) stock including the latest price, news, dividend history, earnings information and financials.

Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Selincro, an orally administered drug for the treatment of alcohol dependence in

Acorda Therapeutics (NASDAQ:ACOR) Shares Down 7.4% ... Acorda Therapeutics Inc (NASDAQ:ACOR)’s share price fell 7.4% during trading on Wednesday . The company traded as low as $2.22 and last traded at $2.26, 2,620,861 shares were traded during mid Acorda Therapeutics Inc (NASDAQ:ACOR) price target set to ... Analyst Ratings For Acorda Therapeutics Inc (NASDAQ:ACOR) Today, HC Wainwright set its price target on Acorda Therapeutics Inc (NASDAQ:ACOR) to $28.00 per share. There are 9 Hold Ratings, 3 Buy Acorda Therapeutics (ACOR) stock price is valued at $1.11 ... 12 days ago · Investors tracking shares of Acorda Therapeutics (ACOR) may be focusing on where the stock is trading relative to its 52-week high and low. At the time of writing, the stock had recently reached at $1.11. At this price, shares can be seen trading -91.80% off of the 52-week high mark and 58.55% away from the 52-week low. Acorda Therapeutics (ACOR) Stock in the Investors Queue ...

Stock quote for Acorda Therapeutics, Inc. Common Stock Common Stock (ACOR) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. ACOR Stock Price and Chart — NASDAQ:ACOR — TradingView View live ACORDA THERAPEUTICS INC chart to track its stock's price action. Find market predictions, ACOR financials and market news. View live ACORDA THERAPEUTICS INC chart to track its stock's price action. Find market predictions, ACOR financials and market news. TradingView . EN. Short term target 2.60. Long term target 4.00. ACOR Price Target - ETF Channel